Patents by Inventor Edouard Collins Nice

Edouard Collins Nice has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Truncated EGF receptor
    Patent number: 7449559
    Abstract: The present invention relates to truncated EGF receptor molecules that exhibit increased binding affinities for EGFR ligands such as EGF and TGF1. The present invention also relates to methods of screening for EGF receptor ligands and methods of treatment which involve the use of these molecules.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: November 11, 2008
    Assignees: Commonwealth Scientific and Industrial Research Organisation, Ludwig Insitutute for Cancer Research
    Inventors: Colin Wesley Ward, Neil Moreton McKern, George Oscar Lovrecz, Robert Nicholas Jorissen, Thomas Peter John Garrett, Thomas Charles Elleman, Antony Wilkes Burgess, Timothy Edward Adams, Teresa Anne Domagala, Edouard Collins Nice
  • Methods of screening based on the egf receptor crystal structure
    Publication number: 20040248196
    Abstract: This invention relates to the structure of members of the epidermal growth factor (EGF) receptor family and to receptor/ligand interactions. In particular, it relates to the field of using the EGF receptor family structure to select and screen for compounds that inhibit the formation of active receptor dimers.
    Type: Application
    Filed: July 14, 2004
    Publication date: December 9, 2004
    Inventors: Timothy Edward Adams, Antony Wilks Burgess, Thomas Charles Elleman, Thomas Peter John Garrett, Robert Nicholas Jorissen, Meizhen Lou, George Oscar Lovrecz, Neil Moreton Mckern, Edouard Collins Nice, Colin Wesley Ward
  • Leukaemia inhibitory factor
    Publication number: 20030004098
    Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF and methods of producing LIF by the expression of the isolated DNA in suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.
    Type: Application
    Filed: February 12, 2001
    Publication date: January 2, 2003
    Inventors: David Paul Gearing, Nicholas Martin Gough, Douglas James Hilton, Julie Ann King, Donald Metcalf, Edouard Collins Nice, Nicos Anthony Nicola, Richard John Simpson, Tracy Ann Willson
  • Leukaemia inhibitory factor
    Patent number: 6261548
    Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF and methods of producing LIF by the expression of the isolated DNA and suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: July 17, 2001
    Assignee: Amrad Corporation Limited
    Inventors: David Paul Gearing, Nicholas Martin Gough, Douglas James Hilton, Julie Ann King, Donald Metcalf, Edouard Collins Nice, Nicos Anthony Nicola, Richard John Simpson, Tracy Ann Willson
  • Leukaemia inhibitory factor
    Patent number: 5750654
    Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF, and methods of producing LIF by the expression of the isolated DNA in suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.
    Type: Grant
    Filed: March 29, 1995
    Date of Patent: May 12, 1998
    Assignee: Amrad Corporation Limited
    Inventors: David Paul Gearing, Nicholas Martin Gough, Douglas James Hilton, Julie Ann King, Donald Metcalf, Edouard Collins Nice, Nicos Anthony Nicola, Richard John Simpson, Tracy Ann Willson